What We’re Reading: Affordable Care Act Update; COVID-19 Booster Effectiveness; Lawsuit Disputes Abortion Pill Ban
Affordable Care Act health care sign-ups are breaking records; updated COVID-19 boosters are proving successful against new variants; GenBioPro, which manufactures mifepristone, has filed suit regarding the constitutionality of a state abortion drug ban.
Record Numbers Pursue Affordable Care Act Health Coverage
This year, a record-breaking 16.3 million people have signed up for insurance coverage during 2023 enrollment under the Affordable Care Act, almost a 50% increase since President Biden took office,
Updated COVID-19 Vaccines Effective Against Newest Variants, Says CDC
Brendan Jackson, MD, MPH, who heads the CDC’s COVID-19 response, said new data show that updated vaccines protect people against the most recent
New Lawsuit Confronts West Virginia Abortion Pill Ban
The company GenBioPro, 1 of 2 American producers of mifepristone, the first pill in a 2-drug medication abortion regimen, filed a lawsuit on Wednesday morning contesting the constitutionality of a state ban on the drug,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025